DBICX
Price
$11.22
Change
-$0.02 (-0.18%)
Updated
Jun 2 closing price
Net Assets
181.67M
MBXIX
Price
$45.82
Change
-$0.15 (-0.33%)
Updated
Jun 2 closing price
Net Assets
10.13B
Interact to see
Advertisement

DBICX vs MBXIX

Header iconDBICX vs MBXIX Comparison
Open Charts DBICX vs MBXIXBanner chart's image
DBICX vs MBXIX Comparison Chart in %
View a ticker or compare two or three
VS
DBICX vs. MBXIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBICX is a Buy and MBXIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXIX has more cash in the bank: 10.1B vs. DBICX (182M). DBICX pays higher dividends than MBXIX: DBICX (1.00) vs MBXIX (0.00). DBICX was incepted earlier than MBXIX: DBICX (25 years) vs MBXIX (10 years). DBICX (2.10) and MBXIX (2.00) have similar cost to investors . MBXIX is a more actively managed with annual turnover of: 19.00 vs. DBICX (12.00). DBICX has a lower initial minimum investment than MBXIX: DBICX (1000) vs MBXIX (2500). MBXIX annual gain was more profitable for investors over the last year : 21.36 vs. DBICX (12.03). MBXIX return over 5 years is better than : 37.51 vs. DBICX (18.79).
DBICXMBXIXDBICX / MBXIX
Total Expense Ratio1.872.0094%
Annual Report Gross Expense Ratio2.102.00105%
Fund Existence25 years10 years-
Gain YTD3.87213.47829%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets182M10.1B2%
Annual Yield % from dividends1.000.00453,336%
Returns for 1 year12.0321.3656%
Returns for 3 years24.5538.0565%
Returns for 5 years18.7937.5150%
Returns for 10 years56.71106.1053%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGFX25.07N/A
N/A
Morgan Stanley Inst Global Franchise C
TQTIX19.85N/A
N/A
AMG TimesSquare International SmallCap I
ARAQX9.98N/A
N/A
Aristotle Value Eq A
PACLX37.16N/A
N/A
T. Rowe Price Capital Appreciation Adv
TSCHX23.16N/A
N/A
Nuveen Quant Small Cap Equity I